NUVB-WS

Nuvation Bio INC -cw27

+$5.3M

Net Activity

Institutions Holding

21

Popularity Rank

#7947

Avg Weight

0.02%

Total Value

$9.9M

Ownership Trend

21 institutions currently hold NUVB-WS, with 6 net buyers and 4 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Majority Increased

Based on recent trading activity

Net Selling Institutions

4

Net Buying Institutions

6

Key Holders

View all 21 holding institutions

Quarterly Activity

Recent Activity

+$404.3K

Total Buy Value

$431.0K

Total Sell Value

New buy2
Trim1
Add4
Sold out3

6

Net Buyers

4

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NUVATION BIO INC -CW27 (NUVB-WS)?
Major stakeholders currently include EcoR1 Capital, LLC ($8.6M), Decheng Capital LLC ($213.2K), Nantahala Capital Management, LLC ($206.6K). Based on the latest 13F filings, there are a total of 21 tracked investment funds and institutions maintaining positions in NUVB-WS.
What is the overall institutional sentiment toward NUVB-WS recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $5.3M, driven by 6 managers accumulating shares while 4 reduced their exposure.
Which institutions have been selling or reducing their NUVB-WS positions?
In the latest period, 1 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $431.0K.
Are there any notable investors adding NUVB-WS to their portfolios?
Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 4 existing holders added to their shares. The total reported buy value for the quarter amounted to $404.3K.

Related Stocks